COVID-19 IgG/IgM Rapid Test - India CDSCO Medical Device Registration

COVID-19 IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_e7bb546ec4b612aacef8c521e317b268_f82f8f673f25f151ec57604d1e8aa4f0. This device is marketed under the brand name Gargle based. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

COVID-19 IgG/IgM Rapid Test

UID: MFG/MD/2018/000029_e7bb546ec4b612aacef8c521e317b268_f82f8f673f25f151ec57604d1e8aa4f0

Brand Name

Gargle based

License Holder

Meril Diagnostics Pvt. Ltd.

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

The Diagnostic Kit (Gargle based) for IgG/IgM Antibody to SARS-COV-2 is a rapid immunoassay for the qualitative detection of antibodies (Gargle based) to SARS-COV-2 virus in Whole Blood / Serum / Plasma